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New findings 
 
What is the central question of this study? 
Does chronic mountain sickness (CMS) alter sympathetic neural control and arterial 
baroreflex regulation of blood pressure in Andean (Quechua) highlanders? 
What is the main finding and its importance? 
Compared to healthy Andean highlanders, basal sympathetic vasomotor outflow is lower, 
baroreflex control of MSNA is similar, supine heart rate is lower, and cardiovagal baroreflex 
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gain is greater in mild CMS. Taken together, these findings reflect flexibility in integrative 
regulation of blood pressure that may be important when blood viscosity and blood volume 
are elevated in CMS. 
Key words: Chronic mountain sickness, excessive erythrocytosis, arterial baroreflex, 
muscle sympathetic nerve activity, blood pressure control 
 
Abbreviations:  
CMS: Chronic mountain sickness 
BP: Blood pressure  
Hb: Haemoglobin concentration  
RRI: R-R interval  
MSNA: Muscle sympathetic nerve activity  
EE: Excessive erythrocytosis   
HR: Heart rate 
SBP: Systolic blood pressure 
DBP: Diastolic blood pressure 
MAP: Mean arterial pressure 
SV: Stroke volume 
Qc: Cardiac output 
TPR: Total peripheral resistance  
PASP: Pulmonary artery systolic pressure 
PE: Phenylephrine  
SNP: Sodium nitroprusside 
SaO2: Arterial oxygen saturation 
PaO2: Arterial oxygen partial pressure   
PaCO2: Arterial oxygen partial pressure   
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Abstract 
High-altitude maladaptation syndrome chronic mountain sickness (CMS) is characterised by 
excessive erythrocytosis and frequently accompanied by accentuated arterial hypoxaemia. 
Whether altered autonomic cardiovascular regulation is apparent in CMS is unclear. 
Therefore, we assessed integrative control of blood pressure (BP) and determined basal 
sympathetic vasomotor outflow and arterial baroreflex function in 8 Andean natives with 
CMS ([Hb] 22.6±0.9g/dL) and 7 healthy highlanders ([Hb] 19.3±0.8g/dL) at their resident 
altitude (Cerro de Pasco, Peru; 4383m). R-R interval (RRI, electrocardiogram), beat-by-beat 
BP (photoplethysmography) and muscle sympathetic nerve activity (MSNA; 
microneurography) were recorded at rest and during pharmacologically-induced changes in 
BP (modified Oxford test). Although [Hb] and blood viscosity (7.8±0.7 vs 6.6±0.7cP; d=1.7, 
P=0.01) were elevated in CMS compared to healthy highlanders, cardiac output, total 
peripheral resistance and mean BP were similar between groups. The vascular sympathetic 
baroreflex MSNA set-point (i.e. MSNA burst incidence) and reflex gain (i.e. responsiveness) 
were also similar between groups (MSNA set-point; d=0.75, P=0.16, gain; d=0.2, P=0.69). In 
contrast, in CMS the cardiovagal baroreflex operated around a longer RRI (960±159 vs 
817±50msec; d=1.4, P=0.04) with a greater reflex gain (17.2±6.8 vs 8.8±2.6msec·mmHg-1; 
d=1.8, P=0.01) versus healthy highlanders. Basal sympathetic vasomotor activity was also 
lower compared to healthy highlanders (33±11 vs 45±13bursts·min-1; d=1.0, P=0.08). In 
conclusion, our findings indicate adaptive differences in basal sympathetic vasomotor activity 
and heart rate compensate for the haemodynamic consequences of excessive erythrocyte 
volume and contribute to integrative blood pressure regulation in Andean highlanders with 
mild CMS.  
  
 
This article is protected by copyright. All rights reserved. 
 
Introduction 
Globally, between 5–10% of the ~140 million people living at high-altitude (>2500m) lack the 
ability to cope with chronic hypoxia and develop a progressively incapacitating 
maladaptation syndrome termed chronic mountain sickness (León-Velarde et al., 2005). 
Chronic mountain sickness (CMS), which is most prevalent in natives of the Andean plateau, 
is characterised by excessive erythrocytosis (EE, haemoglobin concentration [Hb] ≥21g/dL 
for men, ≥19g/dL for women) and is frequently accompanied by accentuated arterial 
hypoxaemia for the resident altitude; and, in more severe stages of the disease, pulmonary 
hypertension (León-Velarde et al., 2005). In addition, CMS individuals may present with a 
number of clinical symptoms including headache, breathlessness, sleep disturbances, and 
cognitive impairment (León-Velarde et al., 2005; Villafuerte & Corante, 2016). Importantly, 
CMS is also associated with an increased cardiovascular disease risk (Corante et al., 2018), 
which increases with disease severity. Specifically, an increased prevalence of thrombotic 
events, stroke, coronary heart disease and systemic and pulmonary hypertension, which can 
give rise to cardiac hypertrophy and congestive heart failure, have all been reported in CMS 
(Monge, 1942; Peñaloza et al., 1971; Leon-Velarde and Arregui, 1994; Leon-Velarde et al., 
2014). Excessive erythrocyte volume and the resulting elevations in haemoglobin and 
hematocrit are known to contribute to this increased risk (Corante et al., 2018; Tremblay et 
al., 2019). However, several other clinical conditions characterised by sustained hypoxaemia 
(i.e. Chronic Obstructive Pulmonary Disease) are often accompanied by arterial baroreflex 
dysfunction and elevated sympathetic vasomotor outflow (van Gestel & Steier, 2010; 
Andreas et al., 2013). Such changes, which can facilitate increased blood pressure 
variability, elevated blood pressure, increased arterial stiffness and vascular dysfunction 
(Smit et al., 2002; Hijmering et al., 2002; Swierblewska et al., 2010), can all contribute to the 
development of cardiovascular disease. Whether arterial baroreflex dysfunction and elevated 
sympathetic vasomotor outflow are also apparent in CMS is unclear.  
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The arterial baroreflex plays a fundamental role in the control of blood pressure 
through its regulation of cardiac pacemaker activity and sympathetic vasomotor outflow. 
Previous research has found impaired baroreflex control of R-R interval (RRI) in Andean 
highlanders with CMS compared to healthy highlanders (Keyl et al., 2003); however, this is 
not a consistent finding (Gulli et al., 2007). Baroreflex control of arterial pressure also occurs 
via alterations in sympathetic vasomotor outflow. Previously, no difference in maximum gain 
(i.e. responsiveness) of carotid baroreflex control of forearm vascular resistance (index of 
sympathetic vasomotor activity) was reported for CMS compared to healthy Andean 
highlanders (Moore et al., 2006). Nevertheless, to the best of our knowledge, no direct 
measurement of sympathetic vasomotor activity exists for CMS individuals. Whilst plasma 
catecholamine concentrations may not accurately represent sympathetic nervous system 
activity (Esler, 1988), they are reported to be either elevated (Gamboa et al., 2006) or 
unchanged (Antezana et al., 1995) in CMS, indicating either an increased or comparable 
global sympathetic activation compared to their healthy Andean counterparts. On one hand, 
elevated sympathetic activity might be predicted in CMS if exaggerated arterial hypoxaemia 
is present; thus augmenting tonic peripheral chemoreflex activation. On the other hand, a 
larger blood volume in CMS (Claydon et al., 2004) might have a sympathoinhibitory effect on 
basal MSNA, as shown in healthy individuals at sea-level (Charkoudian et al., 2004; Best et 
al., 2014).  
In light of the equivocal findings, and absence of microneurographic data for CMS, it 
is unclear what effect CMS has on sympathetic neural control and arterial baroreflex 
regulation of blood pressure in Andean highlanders. The present study, therefore, aimed to 
comprehensively assess integrative regulation of resting blood pressure in Andean 
highlanders with CMS, and to compare this with healthy highlanders. To achieve this we 
assessed blood volume, basal sympathetic vasomotor outflow, and arterial baroreflex control 
of the heart and sympathetic vasomotor outflow. Based upon limited previous reports, we 
hypothesised that 1) the vascular sympathetic baroreflex would operate around a higher 
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MSNA burst incidence for CMS, with no difference in reflex gain (i.e. responsiveness), 
compared to healthy highlanders; 2) the cardiovagal baroreflex would operate around a 
shorter RRI (higher HR) in CMS with a concurrent reduction in reflex gain, therefore, 3) basal 
sympathetic vasomotor outflow and arterial pressure would be elevated for CMS. A 
secondary aim was to determine the contribution of the peripheral chemoreflex to basal 
MSNA and arterial baroreflex function in CMS.  
Methodology 
Ethical approval  
This study was part of the Global REACH high-altitude research expedition to the 
Universidad Peruana Cayetano Heredia’s Instituto de Investigacions de Altura (4380 m; 
Cerro de Pasco, Peru) in July 2018. All experimental procedures had Institutional Review 
Board approval from Universidad Peruana Cayetano Heredia (#101686, date of approval 
20.02.2018) and conformed to the latest revision of the Declaration of Helsinki, except for 
registration in a database. Prior to participation, all experimental procedures were explained 
to subjects in writing, and verbally, in their native language, and written informed consent 
was provided. Participants took part in a number of other studies; however, care was taken 
to ensure adequate recovery between protocols to prevent any potential for confounding 
results. Furthermore, the present study addressed a distinct a priori research question.  
Participants 
Twenty Andean men born at an altitude above 3250 m, permanently residing in the Cerro de 
Pasco area and who had at least two previous known generations of high-altitude Andean 
ancestry were recruited for the study. None of the subjects had travelled to an altitude lower 
than 3000m in the previous six months and did not have a history of working in the mining 
industry. None of the participants were taking prescribed medication and had no prior history 
of cardiovascular, pulmonary, metabolic, neurological or renal disease. Participants attended 
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the laboratory on two occasions, with a minimum of 24 hours between visits 1) preliminary 
screening visit, and 2) experimental visit.  
Preliminary screening visit,  
On arrival to the laboratory, participants provided a detailed clinical history and history of 
high-altitude residence and ancestral background. A venous blood sample was drawn from 
the antecubital vein to measure [Hb], hematocrit and blood viscosity. An arterial blood 
sample was drawn from the radial artery (CG), following local anaesthesia (2% lidocaine), to 
determine arterial blood gases (PaO2 and PaCO2) and arterial oxygen saturation (SaO2). 
Total blood volume (packed cell volume and plasma volume) was determined via the 
modified carbon monoxide (CO) rebreathing method as previously described in detail 
(Schmidt & Prommer 2005) and used previously by our group in lowland and highland 
natives at high-altitude (Stembridge et al., 2018, 2019). Participants also performed an 
incremental exercise test (20 W/min) to exhaustion, in the semi recumbent position, on an 
electronically braked cycle ergometer (Lode Angio; Lode). Breath-by-breath respiratory data 
were collected throughout (Oxycon Mobile; Carefusion) to determine peak oxygen 
consumption (VO2peak). 
Chronic mountain sickness scores were calculated using the Qinghai CMS questionnaire 
based on the presence and severity of eight signs and symptoms of CMS, as agreed by 
international consensus (León-Velarde et al., 2005); EE, heart palpitations, difficulty 
sleeping, cyanosis, parathesia, headache, tinnitus and dilated veins. A value of zero was 
assigned to negative answers. Positive answers were categorised as light, moderate, or 
severe and assigned values of one, two and three respectively. The sum of assigned values 
constituted the CMS score. Subjects were diagnosed with CMS by a score ≥5 in the 
presence of EE ([Hb] ≥21g/dL) and individuals not meeting these criteria were categorised 
as healthy highlanders. The sum of the score defines CMS severity as absent (0–5), mild (6–
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10), moderate (11–14) or severe (≥ 15). Two highlanders (both CMS) were current smokers, 
but refrained from smoking on the day of testing.  
Experimental visit 
Experimental protocol 
All participants were asked to abstain from caffeine, alcohol and vigorous exercise for at 
least 24 hours before to the experimental session and arrived at the laboratory a minimum of 
4 hours after a light meal. Following arrival at the laboratory, subjects rested in the supine 
position and an antecubital venous cannula was inserted for subsequent drug administration. 
Following instrumentation, acquisition of an acceptable MSNA signal and a period of 
stabilisation, 10 minutes of baseline data were recorded to determine resting cardiovascular 
and pulmonary haemodynamics and sympathetic vasomotor activity. A modified Oxford test 
was then performed to assess vascular sympathetic and cardiovagal baroreflex function. 
Following baseline measurements, participants were then transferred to breathing 100% O2, 
in an attempt to eliminate peripheral chemoreceptor drive, as used previously (Simpson et 
al., 2019). Subjects breathed hyperoxia, via a mouthpiece, for a period of five minutes. 
Following five minutes of hyperoxia, a second modified Oxford test was performed, whilst 
subjects continued to breathe hyperoxia, in order to determine the influence of the peripheral 
chemoreflex on arterial baroreflex function. Due to the unknown time course of recovery 
from hyperoxia, the order of conditions was not randomised. A minimum of 20 minutes 
separated each modified Oxford test.  
Experimental measurements 
Haematological analysis 
Venous blood samples were collected into lithium heparin-coated vacutainers (Becton, 
Dickinson and Company, Mississauga, Canada) and tested within 15 minutes of acquisition. 
Arterial blood samples were collected into pre-heparinized syringes (safePICO syringes, 
  
 
This article is protected by copyright. All rights reserved. 
 
Radiometer, Copenhagen, Denmark) for immediate analyses. Whole blood viscosity was 
measured in duplicate at a shear rate 225 s-1 at 37 ºC using a cone and plate viscometer 
(DV2T Viscometer, Brookfield Amtek, USA) and a circulating water heating bath (TC-150, 
Brookfield Amtek, USA). [Hb] and hematocrit, arterial blood gases and SaO2 were 
determined by radiometer ABL90 analyzer (ABL90 Flex, Radiometer, Canada). 
Cardiovascular haemodynamics 
Heart rate and blood pressure were continuously recorded using Lead II electrocardiogram 
and finger photoplethysmography (Finometer Pro; Finapres Medical Systems BV, 
Amsterdam, The Netherlands). Systolic (SBP), diastolic (DBP) and mean (MAP) pressures 
were calculated on a beat-by-beat basis from the finger arterial pressure waveform. 
Finometer values were calibrated against the average of three brachial artery blood pressure 
measurements taken during baseline. Stroke volume (SV) and cardiac output (Qc) were 
estimated using the Model Flow algorithm (Wesseling et al., 1993) and used to estimate total 
peripheral resistance (TPR = MAP/Qc).  
 
Pulmonary Haemodynamics  
Echocardiograhy was used to assess pulmonary artery systolic pressure (PASP). Images 
were obtained using a commercially available system (Vivid Q, GE, Fairfield, CT, USA) and 
stored for subsequent off-line analysis. Pulmonary arterial systolic pressure (PASP) was 
quantified as the maximum systolic pressure gradient across the tricuspid valve added to 
right atrial pressure estimated from the collapsibility of the inferior vena cava, in line with the 
guidelines of the American Society of Echocardiography (Rudski et al., 2010). To derive 
pressure, the modified Bernoulli equation (4·V2) was applied to the peak systolic 
regurgitation jet velocity measured via continuous wave Doppler (Rudski et al., 2010) 
 
Muscle sympathetic nerve activity  
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Multi-unit MSNA was recorded from the peroneal nerve via microneurography as previously 
described (Hagbarth & Vallbo, 1968; Sundolf and Wallin, 1978). MSNA signal was confirmed 
by pulse-synchronous activity that responded to end-expiratory apnea but not to startle 
stimuli or skin stroking. Nerve signals were acquired (Neuroamp EX headstage, 
ADInstruments, Sydney, Australia), amplified (100,000x), filtered (band pass 700-2,000Hz), 
rectified and integrated (decay constant 0.1s) (LabChart Pro v8.3.1, ADInstruments, Sydney, 
Australia). No adverse events or complications occurred during or following the 
microneurography procedure in any subject. 
 
Assessment of Sympathetic and Cardiac Baroreflex function 
Baroreflex function was assessed from the MSNA and RRI (and HR) responses during 
arterial blood pressure perturbations induced by the modified Oxford  test (Rudas et al., 
1999). Briefly, this involved bolus injection of sodium nitroprusside (SNP), followed 90 
seconds later by phenylephrine (PE). Prior to experimental testing, bolus doses of SNP and 
PE that evoked ~15mmHg perturbations above and below resting arterial blood pressure 
were determined for each individual. Briefly, individualized doses of vasoactive drugs were 
calculated based on total blood volume (20μg∙L-1 SNP; 30 μg∙L-1 PE), which were adjusted if 
insufficient BP perturbations were achieved. Identical doses were administered during all 
trials in the same individual. Doses of vasoactive drugs injected were similar in CMS (SNP, 
1.66 ± 0.35 μg∙kg-1; PE, 2.48 ± 0.25 μg∙kg-1) and healthy highlanders (SNP, 1.48 ± 0.30 
μg∙kg-1, P = 0.30 d = 0.5; PE, 2.34 ± 0.42 μg∙kg-1, P = 0.49 d = 0.42) and induced similar 
total blood pressure perturbations in both groups (CMS, 26 ± 5 mmHg; Healthy highlanders, 
25 ± 9 mmHg; P = 0.72, d = 0.11). 
Data analyses  
All haemodynamic data were sampled at 1KHz using a commercial data acquisition software 
(LabChart Pro v8.3.1, ADInstruments, Sydney, Australia) and stored on a laboratory 
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computer for offline analysis. The raw MSNA signal was sampled at 10 KHz. Multi-unit 
bursts of MSNA were identified using an automated detection algorithm (Chart Pro 8.3.1) 
and confirmed by a trained observer (SAB/LLS), using established criteria (White et al., 
2015). To account for sympathetic baroreflex latency, MSNA data were shifted backwards 
(Average shift: CMS -1.23 ± 0.05s, healthy highlanders -1.17 ± 0.05s) so that the peak of 
each sympathetic burst coincided with the diastolic period which initiated it (Simpson et al., 
2019). To account for differences in microelectrode positioning, burst amplitude data were 
normalised by assigning a value of 100 to the largest burst observed during baseline. All 
other bursts were calibrated against this value. Resting sympathetic vasomotor activity was 
quantified as MSNA burst frequency (burst·min-1) and total activity (mean burst amplitude x 
burst frequency [au·min-1]) as it reflects the amount of neurotransmitter release and thus 
vasoconstrictor drive to the vasculature over a given time period (Charkoudian & Wallin, 
2014). 
Baroreflex control of MSNA was assessed from the relationship between i) DBP and MSNA 
burst probability. DBP was used because MSNA correlates more closely with DBP than SBP 
(Sundlof & Wallin, 1978). All DBP values during the modified Oxford test were assigned to a 
3 mmHg bin to reduce the statistical impact of respiratory related oscillations (Eckberg & 
Eckberg, 1982). The percentage of cardiac cycles associated with a burst of MSNA (ranging 
from 0-100%) was calculated for each DBP bin to give values of burst probability. Non-linear 
saturation and threshold regions, if present, were excluded through visual inspection of data 
points by agreement of two observations. The slope of the linear relationship was 
determined by weighted linear regression analysis, and this value provided an index of 
vascular sympathetic vascular baroreflex gain. Only slopes with (i) at least five data points 
and (ii) R≥ 0.5 were included in the group mean data (Hart et al., 2011). Vascular 
sympathetic baroreflex gain for rising and falling pressures were not determined 
independently. The operating point of the vascular sympathetic baroreflex was taken as the 
average value for MSNA burst incidence (burst·100HB-1) and DBP during the baseline 
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period before to the modified Oxford test. In contrast to burst frequency, burst incidence, 
which is temporally independent, is an index of reflex control and baroreflex ‘gating’ of 
sympathetic bursts. Baroreflex control of the heart was assessed from the relationship 
between SBP and RRI/ HR during the modified Oxford test. SBP was used as it correlates 
more closely with RRI and HR than DBP (Sundlof & Wallin, 1978). Values were averaged 
over 3mmHg SBP bins. Baroreflex delays were accounted for by associating SBP values 
with either the concurrent heartbeat (resting RRI <800msec, HR <75 bpm,) or subsequent 
heartbeat (resting RRI >800msec HR >75bpm) (Eckberg & Eckberg, 1982). Saturation and 
threshold regions were excluded by visual inspection, slopes were determined by weighted 
linear regression analysis and only slopes with at least five data points and R ≥0.8 were 
included in the group mean data (Taylor et al., 2015). To minimize the potential effects of 
hysteresis, we restricted data analysis to the rising arm of SBP and used values from the 
nadir to the peak SBP response (Hunt & Farquhar, 2005). The operating point was taken as 
the average values for RRI/HR and SBP during the resting period prior to the modified 
Oxford test.  
 
Statistical analyses 
Differences between groups (CMS vs. healthy highlanders) and between conditions 
(baseline vs. hyperoxia) were assessed using pre-planned contrasts. To address hypothesis 
1, 2 and 3, differences in arterial baroreflex function, basal sympathetic vasomotor activity 
and arterial pressure, between CMS and healthy highlanders, were assessed using 
independent T-tests. To address our secondary aim and examine the contribution of the 
peripheral chemoreflex mechanism, differences in arterial baroreflex function, sympathetic 
vasomotor activity and arterial pressure in CMS and healthy highlanders between baseline 
and hyperoxia were assessed using dependent T-tests. Significant cardiovagal baroreflex 
slopes (R ≤ 0.8) were not obtained in one CMS participant and one healthy highlander; 
therefore cardiovagal baroreflex gain analyses at baseline were based on seven CMS 
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participants and six healthy highlanders. As a result of MSNA signal losses, repeated 
measures comparisons for cardiovascular haemodynamics and sympathetic neural activity 
during hyperoxia were performed on six CMS participants and six healthy highlanders. 
Furthermore, during hyperoxia, cardiovagal baroreflex slopes did not meet the inclusion 
criteria (R ≤ 0.8) in one out of six healthy highlanders; therefore, repeated measures 
comparisons for cardiovagal baroreflex gain are limited to five healthy highlanders and six 
CMS individuals. Multiple t-tests were chosen to maximize the number of subjects included 
in statistical analyses. To correct for multiple comparisons, a priori alpha was adjusted, using 
the experiment-wise error rate (Hinkle et al., 2003) as used previously (Busch et al., 2017; 
Simpson et al., 2019). Statistical significance was set at P < 0.05. Furthermore, due to a 
small sample size, Cohen’s d effect sizes are also reported with d ≥ 0.8 indicative of large 
effects (Cohen., 1988). Normality was assessed using Shapiro-Wilk test, and data that was 
not normally distributed underwent log10 transformation prior to analysis. All statistical 
analyses were performed using Prism 7.03 (GraphPad software, USA). Data are presented 
as means ± SD. Differences between groups and conditions are also reported as mean 
difference and (95% confidence interval). 
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Results 
Participant characteristics 
Although twenty participants were recruited for the study; an MSNA signal could not be 
obtained in five of them; therefore data is presented for fifteen participants. We tested eight 
CMS individuals with a mean ± SD CMS score of 8 ± 2 (range 5–11) and seven healthy 
highlanders with a CMS score of 1 ±1 (range 0–3). Seven CMS participants were classified 
as having mild CMS and one was classified as having moderate CMS. CMS participants 
were similar in age (40 ± 12 yrs), weight (69 ± 12 kg), height (1.61 ± 0.06 m) and body mass 
index (BMI; 26.4 ± 4.9 kg∙m-2) to healthy highlanders age (45 ± 12 yrs; d = 0.42, P = 0.39), 
weight (71 ± 11 kg; d = 0.18, P = 0.79), height (1.61 ± 0.03 m; d = 0, P = 0.97), BMI (26.5 ± 
3.8 kg∙m-2; d = 0.21, P = 0.74). VO2peak values were also similar in CMS and healthy 
highlanders (32.9 ± 10.5 vs 28.7 ± 8.8 mL∙kg-1∙min-1; d = 0.43, P = 0.49) 
Resting cardiovascular haemodynamics, basal sympathetic neural activity  
SaO2 and PaO2 were lower and PaCO2 was higher in CMS compared to healthy highlanders 
(Table 1). As expected, haemoglobin concentration, haematocrit and blood viscosity (7.8 ± 
0.7 vs 6.6 ± 0.7 cP; d = 1.7, P = 0.01) were all higher in CMS (Table 1). Although not 
statistically significant, total blood volume tended to be larger in CMS compared to healthy 
highlanders (101 ± 25 vs 85 ± 16 mL·kg-1; d = 0.8, P = 0.2), which was due to a larger total 
red blood cell volume, with a similar plasma volume between groups (Table 1, Figure 1). 
CMS also tended to exhibit a greater SV (76 ± 13 vs 64 ± 19 mL; d = 0.8, P = 0.32,) and had 
a lower HR (64 ± 10 vs 74 ± 4 bpm; d = 1.4, P = 0.03) compared to healthy highlanders, with 
a similar Qc in both groups (4.8 ± 0.7 vs 4.7 ± 1.3 L∙min-1; d = 0.1, P = 0.83). TPR was also 
similar between CMS and healthy highlanders (19.2 ± 6.2 vs 19.9 ± 5.5); however CMS 
exhibited a lower MSNA burst frequency (33 ± 11 vs 45 ± 13 burst·min-1; d = 1.0, P = 0.08) 
compared to healthy highlanders (Figure 1). Because Qc and TPR were comparable, MAP 
was also similar in CMS compared to healthy highlanders (Figure 1). Unfortunately, due to 
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the difficulty in identifying the tricuspid value regurgitant jet in four participants we could only 
obtain pulmonary artery systolic pressure (PASP) measurements in seven CMS and four 
healthy highlanders. PASP values were not significantly different between groups (Table 1). 
Arterial baroreflex function 
Vascular sympathetic baroreflex gain (i.e. slope of the DBP-MSNA burst probability 
relationship) was comparable in CMS and healthy highlanders (-2.5 ± 0.9 vs -2.7 ± 1.1 
%·mmHg-1; d = 0.2, P = 0.69, mean diff 0.2 [-0.9 to 1.3]). The operating DBP was also 
similar in both groups (71 ± 4 vs 74 ± 9; d = 0.5, P = 0.41, mean diff -3 [-11 to 4]).The MSNA 
set-point appeared lower in CMS compared to healthy highlanders (51 ± 12 vs 62 ± 17 
bursts∙100Hb-1; d = 0.75, P = 0.16, mean diff -11 [-28 to 8]), although this was not 
statistically significant (Figure 2A).  
Cardiovagal baroreflex gain (i.e. slope of the relationship between RRI and SBP) was 
greater in CMS compared to healthy highlanders (17.2 ± 6.8 vs 8.8 ± 2.6 msec·mmHg-1; d = 
1.8, P < 0.01, mean diff 8.4 [2.7 to 15.0]; Figure 2B). These findings were similar regardless 
of whether RRI or HR was used. Operating SBP was similar in both groups (CMS, 109 ± 8 
vs healthy highlanders, 113 ± 15 mmHg; d = 0.4, P = 0.5, mean diff – 4 [-17 to 8]); however 
CMS participants operated around a longer RRI (960 ± 159 vs 817 ± 50 msec; d = 1.4, P = 
0.04, mean diff -143 [-7 to -279]; Figure 2).  
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Table 1. Haematological variables and resting pulmonary haemodynamics in CMS (n=8) and 
healthy highlanders (n=7). RBC = red blood cell. Data presented as mean ± SD. † Values 
based on six CMS and five healthy highlanders ♦ Values based on seven CMS and four 
healthy highlanders. Statistical comparisons performed using independent t-tests 
  
 
CMS  
Healthy 
highlanders  
P value Cohen’s d 
Mean difference 
(95% CI) 
Haematological variable      
Haemoglobin (g/dL) 22.6 ± 0.9 19.3 ± 0.8 <0.01 3.9 3.3 (2.2 to 4.2) 
Haematocrit (%) 65 ± 5 57 ± 3 <0.01 2.0 8 (3 to 13) 
SaO
2
 (%)† 82 ± 2 87 ± 3 0.01 2.0 -5 (-9 to -2) 
PaO
2
 (mmHg)† 47 ± 2 51 ± 4 0.05 1.4 -4 (-8 to 0) 
PaCO
2
 (mmHg)† 34 ± 1 29 ± 4 0.02 1.9 5 (1 to 9) 
RBC volume (mL·kg-1) 57 ± 14 48 ± 8 0.19 0.8 9 (-5 to 21) 
Plasma volume (mL·kg-1) 41 ± 9 42 ± 9 0.87 0.1 -1 (-11 to 9) 
Pulmonary haemodynamics      
PASP (mmHg) ♦ 29 ± 7 33 ± 7  0.4 0.6 -4 (-14 to 6) 
Table 1.       
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Figure 1. Group mean (±SD) and individual data for haematological and cardiovascular 
haemodynamic variables in CMS (n=8) and healthy highlanders (n=7). Blood viscosity 
values based on six CMS and five healthy highlanders. Statistical comparisons performed 
using independent t-tests. P values are reported with Cohen’s d effect sizes (d) and mean 
differences (95% confidence intervals).  
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Figure 2. Arterial baroreflex function. Group average regressions between A) diastolic BP 
and MSNA burst probability in CMS (n=8) and healthy highlanders (n=7) and B) systolic BP 
and R-R interval in CMS (n=7) and healthy highlanders (n=6). The set-points of the vascular 
sympathetic and cardiovagal limb of the baroreflex are indicated by the symbols and error 
bars (mean ± SD). The arterial baroreflex set points and slopes were compared using 
independent t-tests. * P <0.05 versus healthy highlanders. The vascular sympathetic 
baroreflex set-point was similar between CMS and healthy highlanders. The slope of the 
relationship between diastolic BP and MSNA burst probability was also similar between 
groups, indicating no differences in reflex gain. The cardiovagal baroreflex operated around 
a similar systolic BP, but a greater RRI set-point in CMS compared to healthy highlanders. 
The slope of the relationship between systolic BP and R-R interval was also greater in CMS, 
indicating a greater reflex gain. 
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Arterial baroreflex–peripheral chemoreflex interactions 
In CMS participants exposed to 100% O2, HR significantly decreased and Qc also tended to 
decrease, although this didn’t achieve significance (d = 0.6, P = 0.07). Oxygen 
administration had no effect on any other cardiovascular haemodynamic variable in CMS. 
HR and Qc both significantly decreased in healthy highlanders exposed to 100% O2. This 
reduction in Qc, was accompanied by an increase in TPR, with no significant effect on BP. 
The reduction in HR in both groups was accompanied by a lowering of MSNA burst 
frequency, with no effect on burst amplitude (Table 2).  
Administration of oxygen had no significant effect on vascular sympathetic baroreflex gain, 
operating DBP or MSNA set-point in either CMS or healthy highlanders. Administration of 
oxygen had no effect on cardiovagal baroreflex gain (18.8 ± 9.7 to 20.3 ± 7.4 msec·mmHg-1; 
d = 0.2, P = 0.7; Figure 3) or operating SBP in CMS, but RRI was longer. In healthy 
highlanders administration of oxygen also increased RRI; cardiovagal baroreflex gain was 
greater (8.0 ± 2.6 to 14.1 ± 4.9 msec·mmHg-1; d = 1.6, P = 0.01), with no change in 
operating SBP (Figure 3). 
  
  
 
This article is protected by copyright. All rights reserved. 
 
Table 2 Haemodynamics, MSNA and arterial baroreflex function at baseline and during hyperoxia in 
CMS (n = 6) and healthy highlanders (n = 6). Data presented as mean ± SD. Statistical comparisons 
performed using dependent t-tests. 
 Baseli
ne 
Hypero
xia 
   Baseline Hyperox
ia 
   
 CMS  CMS  P 
val
ue 
Cohe
n’s d 
Mean 
differe
nce 
(95% 
CI) 
Healthy 
highlan
ders  
Healthy 
highlan
ders  
P 
val
ue 
Cohe
n’s d 
Mean 
differe
nce 
(95% 
CI) 
Haemodynamics 
Heart rate 
(bpm) 
60 ± 
10 
54 ± 14 <0.
01 
0.5 -6 (-10 
to -3) 
69 ± 7 61 ± 6 0.0
3 
1.2 -8 (-14 
to -1) 
R-R interval 
(msec) 
1019 
164 
1175 
263  
0.0
1 
0.7 156 
(52 to 
262) 
880 ± 
89 
905 ± 
100 
0.0
3 
0.3 25 (17 
to 207) 
Stroke 
volume 
(mL) 
92 ± 6 93 ± 12 0.9
5 
0.1 0.6 (-
16 to 
18) 
80 ± 21 82 ± 26 0.7
2 
0.1 1.8 (-8 
to 12) 
Cardiac 
output 
(L·min
1
) 
5.6 ± 
1.1 
4.9 ± 
1.2 
0.0
7 
0.6 -0.7 (-
1.4 to 
0.1) 
5.4 ± 
1.1 
4.9 ± 
1.4 
0.0
5 
0.4 -0.5 (-
0.9 to -
0.2) 
TPR 
(mmHg·L·m
in
1
) 
16.0 
± 3.2 
17.9 ± 
4.9 
0.1
8 
0.5 1.9 (-
1.3 to 
5.1) 
17.6 ± 
5.7 
20.5 ± 
7.9 
0.0
1 
0.4 2.9 
(0.3 
to) 
Diastolic BP 
(mmHg) 
73 ± 
12 
71 ± 12 0.2
0 
0.2 -2 (-4 
to 1) 
74 ± 5 77 ± 6 0.1
5 
0.5 3 (-1 to 
6) 
Systolic BP 
(mmHg) 
118 ± 
8 
115 
±10 
0.1
3 
0.3 -3 (-6 
to 1) 
115 ± 7 120 ± 
12 
0.1
3 
0.5 5 (-2 to 
13) 
MAP 
(mmHg) 
89 ± 9 89 ± 5 0.1
5 
0.2 -2 (-4 
to 1) 
87 ± 11 92 ± 7 0.1
1 
0.5 3 (-1 to 
8) 
Sympathetic neural activity 
Burst 
frequency 
(burst·min1
32 ± 
13 
29 ± 13 0.0
2 
0.7 -3 (-6 
to -1) 
41 ± 16 33 ± 13 0.0
4 
0.7 -8 (-16 
to -
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) 0.7) 
Burst 
incidence 
(bursts·100
HB1) 
51 ± 
14 
53 ± 13 0.3
7 
0.2 2 (-2 to 
5) 
60 ± 20 54 ± 21 0.1
5 
0.2 -6 (-13 
to 3) 
Normalized 
burst 
amplitude 
(au) 
56 ± 8 55 ± 13 0.9
9 
0.2 2 (-10 
to 9) 
57 ± 5 54 ± 13 0.7
8 
0.2 2 (-10 
to 13) 
Total 
activity 
(au·min1) 
1780 
± 801 
1618 ± 
922 
0.1
9 
0.4 -162 (-
473 to 
149) 
2335 ± 
900 
1992 ± 
1026 
0.0
8 
0.4 -343 (-
728 to 
42) 
 
 
 
Figure 3. Cardiovagal baroreflex gain: Individual and group average slopes for the 
relationship between RRI and systolic blood pressure at baseline and during hyperoxia in 
CMS (n=5) and healthy highlanders (n=6). Administration of oxygen had no effect on 
cardiovagal baroreflex gain in CMS but, increased cardiovagal baroreflex gain (8.0 ± 2.6 to 
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14.1 ± 4.9 msec·mmHg-1; d = 1.6, P = 0.01) in healthy highlanders. Statistical comparisons 
performed using dependent t-tests.   
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Discussion 
The major findings of the present study are threefold: i) CMS individuals and healthy 
highlanders exhibit similar vascular sympathetic baroreflex gain (i.e. responsiveness), 
operating diastolic pressure, and MSNA set-point (i.e. MSNA burst incidence); ii) however, in 
mild CMS, the cardiovagal baroreflex operates around a longer RRI (lower heart rate) with a 
greater reflex gain; iii) CMS individuals have comparable cardiac output, total peripheral 
resistance, and thus, arterial pressure compared to healthy highlanders. However, CMS 
individuals exhibit a greater haemoglobin concentration, total blood volume and blood 
viscosity, and lower basal vasomotor sympathetic activity (i.e. MSNA burst frequency) 
compared to healthy highlanders. Taken together, these findings indicate adaptive changes 
in autonomic regulation of blood pressure homeostasis in Andean highlanders with mild 
CMS. 
Basal sympathetic vasomotor activity in Andeans 
The one previous study that has assessed resting sympathetic vasomotor activity in Andean 
high-altitude natives found comparable basal MSNA in healthy Bolivian Andeans (Aymara) 
and acclimatising lowlanders (Lundby et al., 2018). However, we are the first to assess basal 
sympathetic vasomotor activity in Peruvian (Quechua) Andeans, including individuals with 
CMS. We observe a 25% lower basal MSNA in CMS compared to healthy highlanders, as 
indicated by a reduced MSNA burst frequency (Figure 1). This finding is in contrast to our 
hypothesis that basal sympathetic vasomotor activity would be greater in CMS, which was 
based upon previous studies reporting either comparable (Antezana et al., 1995) or elevated 
(Gamboa et al., 2006) plasma noradrenaline levels in individuals with CMS. A reduced 
glomerular filtration rate, (Lozano et al., 1964) and thus noradrenaline clearance, in CMS 
would, however, serve to overestimate sympathetic activation using this method, and 
potentially explain these contradictory findings. Despite this, it might be anticipated that 
sympathetic vasomotor activity would be elevated in CMS individuals due to several factors. 
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These factors include: exaggerated arterial hypoxaemia (lower PaO2), reports of increased 
inflammation and oxidative stress (Bailey et al., 2013, Bailey et al., 2019); and, a reduced 
NO bioavailability, all of which exert known sympathoexcitatory effects (Patel et al., 2001). 
Sympathetic vasomotor outflow, however, is the net effect of the integration of both 
excitatory and inhibitory inputs to the cardiovascular control centres in the brainstem. For 
example, elevations in blood volume exert a sympathoinhibitory influence on basal MSNA 
(Charkoudian et al., 2004, Best et al., 2014). Notably, CMS individuals in the present study 
exhibited a 20% greater blood volume compared to healthy highlanders (Figure 1). Whilst 
not statistically significantly different, the effect was large (Cohen’s d = 0.8) and the 
differences were comparable to those previously reported in this population (Claydon et al., 
2004). Thus, lower basal sympathetic vasomotor activity in CMS could be mediated by an 
increase in circulating blood volume. Indeed, we have previously demonstrated a lower 
basal sympathetic activity in high-altitude native Sherpa, compared to acclimatising 
Lowlanders (Simpson et al., 2019), with Sherpa also exhibiting a greater total blood volume 
(Stembridge et al., 2019). Despite this, however, there was no significant correlation 
between these factors in the present study (data not shown). It is also important to note, 
however, that individuals with CMS were on average ~5 years younger than healthy 
highlanders. Although, the reported ~3 bursts·min-1 increase in basal MSNA per decade of 
life (Narkiewicz et al., 2005) would not exclusively explain the observed 12 burst·min-1 
difference in basal MSNA.   
Arterial baroreflex function in Andeans 
This is the first study to assess baroreflex control of MSNA in Andean high-altitude natives.  
In addition, it is the first to simultaneously assess the vascular sympathetic and cardiovagal 
limbs of the arterial baroreflex in the same group. We demonstrated that both CMS and 
healthy highlanders exhibit a similar ability to increase and decrease MSNA in response to 
transient, pharmacologically induced changes in blood pressure (i.e. the vascular 
sympathetic baroreflex gain was unchanged). This is consistent with one previous report of a 
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similar reflex gain for carotid baroreflex control of forearm vascular resistance (Moore et al., 
2006) in both CMS and healthy highlanders. Contrary to our hypothesis, resting heart rate 
was lower, and the ability to alter RRI during the modified Oxford test was greater in CMS 
compared to healthy highlanders. The operating diastolic pressure for the vascular 
sympathetic baroreflex and the operating systolic pressure for the cardiovagal baroreflex 
were similar in CMS and healthy highlanders. Furthermore, MSNA burst incidence (i.e. 
vascular sympathetic baroreflex set-point) was also not significantly different between 
groups, meaning the probability of a burst occurring per cardiac cycle was similar between 
CMS and healthy highlanders. Therefore, our data indicate that CMS does not influence the 
arterial baroreflex control and gating of sympathetic bursts. Importantly, however, a lower 
resting heart rate in CMS reduces the opportunities (i.e. cardiac cycles) for a burst to occur. 
Thus, the interaction of a similar MSNA burst incidence (i.e. vascular sympathetic baroreflex 
set-point) and lower resting heart in CMS reduces MSNA burst frequency (i.e. basal 
sympathetic vasomotor activity). It should be noted that, in contrast to our findings, several 
studies report higher, rather than lower, resting heart rates and/or blood pressures for CMS 
(Keyl et al., 2003; Claydon et al., 2004; Richalet et al., 2005, Corante et al., 2018). The 
reasons for these differences are unclear, although differences in posture, measurement 
technique, time of day for measurement, and the duration of the measurement period, all 
might contribute. In addition, CMS severity may also be important; indeed, studies that report 
higher resting heart rates and blood pressures for CMS also report greater average Hct and 
CMS scores than those observed in the present study. Moreover, a positive correlation has 
been observed between [Hb] and blood pressure in the Cerro de Pasco population 
(Gonzales & Tapia, 2013). Importantly in the present study, cardiac output, total peripheral 
resistance, and thus, arterial pressure for CMS are comparable to healthy highlanders; this 
is despite greater blood viscosity and total blood volume, secondary to an increase in red 
blood cell volume, in CMS. Thus, the lower sympathetic vasomotor outflow and heart rate in 
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CMS appear to balance the haemodynamic effects of EE, which maintains blood pressure 
homeostasis, at least in mild CMS studied here.  
Influence of peripheral chemoreflex on arterial baroreflex function in Andeans 
Lower PaO2 in CMS individuals would be expected to increase peripheral chemoreflex 
activation and potentially reset the arterial baroreflex to operate at higher heart rates, arterial 
pressures and level of MSNA (Halliwill and Minson et al., 2002, Steinback et al., 2009). 
Importantly, however, peripheral chemoreceptor ventilatory responsiveness to hypoxia is 
reported to be blunted in CMS individuals (León-Velarde & Richalet, 2006, Severinghaus et 
al., 1966), contributing to alveolar hypoventilation (higher PaCO2) reported in this population 
(León-Velarde & Richalet, 2006). Despite a blunted ventilatory responsiveness reported in 
CMS the peripheral chemoreflex mechanism did not appear to contribute to the lower HR in 
CMS, as acutely eliminating peripheral chemoreceptor drive, via 100% oxygen 
administration, had comparable effects on HR in both groups. Interestingly, MSNA burst 
incidence remained unchanged for CMS during acute hyperoxia, whilst it was reduced (~ 6 
bursts∙100HB-1) for healthy highlanders. However, this reduction in MSNA burst incidence 
occurred alongside a small increase in both arterial pressure (~3mmHg) and stroke volume; 
therefore, such reductions were likely arterial baroreflex-mediated. In addition, whilst other 
hemodynamic responses to hyperoxia were comparable between groups, there was a 
significant reduction in TPR in healthy highlanders; this was not observed in CMS. This may 
indicate different intrinsic control and regulation of vascular tone; that is healthy highlanders 
possess a greater vascular responsiveness to hypoxia compared with CMS. Indeed, this 
could contribute, in part, to the observed difference in basal MSNA (i.e. extrinsic control) 
under ambient hypoxic conditions. However, any potential difference in local control cannot 
be determined from the data presented here. 
An inhibitory relationship exists between the peripheral chemoreflex and baroreflex 
mechanisms (Somers et al., 1991), whereby an acute increase in peripheral chemoreflex 
activation is consistently shown to inhibit baroreflex control of the heart (Heistad & Wheeler, 
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1971; Sagawa et al., 1997; Steinback et al., 2009; Niewinski et al., 2014; Mozer et al., 2016) 
with inconsistent effects on baroreflex control of MSNA (Halliwill & Minson, 2002; Simpson et 
al., 2019). In the present study, during ambient air breathing, we observed a greater 
cardiovagal baroreflex responsiveness for CMS compared to healthy highlanders. 
Furthermore, we observed no change in cardiovagal baroreflex responsiveness for CMS 
during acute hyperoxia, but demonstrated a 75% increase in reflex gain for healthy 
highlanders. These findings indicate a peripheral chemoreflex-mediated inhibition of 
cardiovagal baroreflex responsiveness in healthy Andeans at high-altitude, which does not 
appear to be present in CMS. This raises an interesting possibility that whilst a blunted 
peripheral chemoreflex responsiveness may contribute to the exaggerated arterial 
hypoxaemia in CMS, it may, paradoxically, prevent the reduced cardiovagal baroreflex gain 
normally observed during sustained high-altitude exposure (Yazdani et al., 2016; Bourdillon 
et al., 2018; Simpson et al., 2019).  
Implications 
Our findings imply that elevated sympathetic vasomotor outflow and arterial baroreflex 
dysfunction do not contribute to the elevated cardiovascular disease risk reported in mild 
CMS, since autonomic control of blood pressure is well maintained in the group studied 
here. Therefore, other factors may predispose individuals with CMS to cardiovascular 
disease. However, we cannot exclude the possibility that elevated sympathetic vasomotor 
outflow and/or arterial baroreflex dysfunction may develop in more severe CMS, with 
elevated pulmonary arterial pressure (Simpson et al., 2020), which may contribute to the 
greater cardiovascular disease risk reported in moderate and severe CMS. 
Experimental limitations 
There are several limitations in the present study that should be acknowledged. First, due to 
time constraints, only small opportunistic samples could be studied. Therefore, meaningful 
differences between groups may not have been detected due to low statistical power. 
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Indeed, insufficient statistical power likely prevented a meaningful 20% difference in both 
total blood volume between groups from being detected, despite a similar magnitude of 
difference to previous studies (Claydon et al., 2004). Second, given the time constraints 
associated with expedition research, it was not possible to control for the time of day that 
participants were tested; therefore, diurnal variations in basal MSNA, blood pressure and 
cardiovagal baroreflex gain (Taylor et al., 2011) are a consideration in our interpretation. 
Notably, our analysis indicates that time of day was not a significant covariate. Third, two 
CMS individuals were light to moderate smokers. It is reported that tobacco smoking leads to 
increased basal MSNA and attenuates vascular sympathetic baroreflex gain (Middlekauff et 
al., 2013), which may have influenced our results. However, this would have potentially 
overestimated resting MSNA in CMS, which would not have altered the interpretation of our 
results (i.e. lower sympathetic vasomotor outflow in CMS). Fourth, due to a lack of CMS 
positive female volunteers, we only studied males; meaning that the findings cannot be 
generalised to females, who likely exhibit differences in blood pressure control mechanisms. 
Last, we did not assess vascular sympathetic baroreflex gain to rising and falling pressure 
independently, due to an insufficient number of data points to construct baroreflex slopes 
that met the criteria for inclusion. We acknowledge that this fails to take baroreflex hysteresis 
into account (Rudas et al., 1999).  
Conclusion 
Contrary to our hypotheses, elevated sympathetic vasomotor outflow and arterial baroreflex 
dysfunction are not apparent in mild CMS. In fact, basal sympathetic vasoconstrictor drive 
and heart rate are lower in CMS, with enhanced cardiovagal baroreflex gain, compared to 
healthy highlanders. Such changes appear to be adaptive physiological responses to the 
elevations in red blood cell volume, which allow blood pressure homeostasis to be 
maintained. Furthermore, whilst a blunted peripheral chemoreflex is reported to be a 
possible mechanism responsible for accentuated arterial hypoxaemia in CMS, it may, 
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paradoxically, augment cardiovagal baroreflex responsiveness compared to healthy 
highlanders. 
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